Skip to main content

epinephrine

Generic: EPINEPHRINE·Brand: ADRENACLICK, ADRENALIN, AUVI-Q, Adrenalin, Articadent, Auvi-Q, BRONKAID MIST, Citanest Forte, EPI E Z PEN JR, EPINEPHRINE, EPINEPHRINE (AUTOINJECTOR), EPIPEN, EPIPEN E Z PEN, EPIPEN JR., Epipen, Lignospan, Marcaine with Epinephrine, NEFFY, Neffy, Orabloc, PRIMATENE MIST, Primatene Mist Inhaler, SUS-PHRINE SULFITE FREE, SYMJEPI, Sensorcaine with Epinephrine, Septocaine, Symjepi, TWINJECT, Ultacan, Vivacaine, Xylocaine with Epinephrine, Zorcaine

epinephrine: 7 clinical trials tracked.

epinephrine evidence translation

What we can confirm

7 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about epinephrine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence7 indications · 3 study sponsors
Clinical Trials (7)

Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of MK-2010 in Combination With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Advanced Solid Tumors

NCT07785609·Phase 2
Not yet recruiting

Primary endpoint: Number of Participants Who Experience an Adverse Event (AE)

Interventionalopen200 targetStarted 2026-09Completion 2031-09Merck Sharp & Dohme LLC

Efficacy of Ropivacaine Epinephrine Clonidine Ketorolac (R.E.C.K) vs Exparel in Robotic Nephrectomy: a Randomized, Prospective Trial

NCT07092566·Phase 3
Recruiting

Primary endpoint: Area Under the Curve (AUC) of the Numeric Rating Scale (NRS) pain intensity scores through 7 days (168 hours) for participants receiving Exparel vs. R.E.C.K.

InterventionalRandomizedopen170 targetStarted 2025-11Completion 2027-101 site · United StatesWake Forest University Health Sciences

An Outpatient, Randomized, Double-Blinded, Placebo-Controlled, Cross-Over Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria

NCT06927999·Phase 2·SPRY
Recruiting

Primary endpoint: Determine the effect of ARS-2 (0.5 mg or 1 mg) versus placebo on itch and hive

InterventionalRandomizeddouble42 targetStarted 2025-07Completion 2027-063 sites · Germany, United StatesARS Pharmaceuticals, Inc.

A Randomized Controlled Trial of Bupivacaine With Epinephrine for Local Pain Control Following Perineal Laceration Repair in Patients With Pre-existing Epidural Analgesia: The PAIN Trial

NCT05972681·Phase 4
Terminated

Primary endpoint: Time to First Analgesic

InterventionalRandomizedquadruple3 targetStarted 2025-04Completion 2025-101 site · United StatesMontefiore Medical Center

Multimodal Nonopioid Pain Protocol Following Shoulder Arthroplasty Surgery

NCT05488847·Phase 4·FLNA
Active, not recruiting

Primary endpoint: Pain Levels

InterventionalRandomizedsingle83 targetStarted 2022-06Completion 2026-091 site · United StatesHenry Ford Health System

Intracoronary Administration of Epinephrine and Verapamil in the Refractory No-reflow Phenomenon in Patients With Acute Myocardial Infarction: The EPIVER Randomized Controlled Trial

Completed

Primary endpoint: Mortality

InterventionalRandomizedopen104 enrolledStarted 2020-12Completion 2024-011 site · RussiaTomsk National Research Medical Center of the Russian Academy of Sciences

Phase I/II Trial of HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PD-L1/TGF-Beta Trap (M7824) in Subjects With HPV Positive Cancers

NCT04432597·Phase 1·ARWR
Active, not recruiting

Primary endpoint: Safety and recommended phase II dose of PRGN-2009

Interventionalopen39 targetStarted 2020-08Completion 2026-031 site · United StatesNational Cancer Institute (NCI)